Marc Scherlinger

27PUBLICATIONS
43CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AllergyMedical molecular engineering of nucleic acids and proteinsSocial epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Oct 07, 2026
Next-generation immune cell engagers for B cell depletion in autoimmune diseases.

|May 13, 2026
Relapse risk of lupus-related serositis according to immunosuppressive therapy: a national real-world study.

|May 07, 2026
Carbon Footprint of Antibody-Based Drugs and Biologics Using Hybrid Life Cycle Assessment.

|Feb 18, 2026
Discordance Between Patients and Physicians on Key Determinants of Systemic Lupus Erythematosus Burden: Insights From a French Comprehensive Survey.

Laurent Chiche, Hervé Devilliers, Romane Vallée

|Jan 26, 2026
Roads and detours for CAR T cell therapy in autoimmune diseases.

Jérôme Avouac, Adi Barzel, Delma Caiati

|Sep 24, 2025
Development and validation of LUPIN: a patient-centred self-administered tool to assess disease activity and patient-reported outcomes in systemic lupus erythematosus.

Marc Scherlinger, Jean-Francois Kleinmann, Antonin Folliasson

Pageof 5

Frequent Collaborators

9 joint publications

George C Tsokos

3 joint publications

Maria G Tsokos

3 joint publications

Christophe Richez

2 joint publications

Estibaliz Lazaro